Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Journal of Chemical Physics|January 21, 2006
Patch-distribution effect on diffusion-limited process in dilute suspension of partially active spheresJui-Chuang Wu, Shih-Yuan LuBiomedicines|January 21, 2023
METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate CancerJui-Chuang Wu, Guang-Jer WuSensors (Basel, Switzerland)|March 8, 2014
Electrophoresis-enhanced detection of deoxyribonucleic acids on a membrane-based lateral flow strip using avian influenza H5 genetic sequence as the modelJui-Chuang Wu, Chih-Hung Chen, Ja-Wei Fu, et al.Journal of the Taiwan Institute of Chemical Engineers|May 5, 2020
Effect of co-axially hybridized gene targets on hybridization efficiency of microarrayed DNA probesKai Ren Jiang, Jie-Len Huang, Chia-Chun Chen, et al.Biomaterials|July 26, 2011
Three-dimensional arrayed amino aerogel biochips for molecular recognition of antigensYen K Li, Yun-Chu Chen, Kai-Jen Jiang, et al.Acta Biomaterialia|October 13, 2009
A novel three-dimensional aerogel biochip for molecular recognition of nucleotide acidsYen Kuang Li, Den-Kai Yang, Yun-Chu Chen, et al.Diagnostics (Basel, Switzerland)|April 3, 2021
Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow ImmunoassayJui-Chuang Wu, Yin-Huan Chuang, Yu-Chun Wei, et al.Asian Pacific Journal of Cancer Prevention : APJCP|August 24, 2025
METCAM/MUC18 is a Biomarker and Therapeutic Target for Prostate CancerGuang-Jer Wu, Chia-Chi Hsieh, Yan-Cheng Fu, et al.Cancer Biomarkers : Section a of Disease Markers|January 21, 2020
METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassayYuan-Hung Pong, Yann-Rong Su, Hsing-Wen Lo, et al.Pageof 1